Key factors driving the market include technological advancement in radiation therapy equipment, global rise in cancer cases, and increasing adoption of radiation therapy in oncology treatment.
Accuray Incorporated ARAY recently announced that its Radixact SynC System and CyberKnife S7 System have been approved by the Chinese National Medical Products Administration. These approvals are ...